Novartis · 2 hours ago
Head Portfolio Strategy & Operations Neuroscience & Gene Therapy
East Hanover, NJ
Full-time
Onsite
Director/Executive
$225K/yr - $419K/yr
10+ years expNovartis is a leading company in the pharmaceutical industry, and they are seeking a Head of Portfolio Strategy & Operations for their Neuroscience and Gene Therapy divisions. This role involves leading the therapeutic area and portfolio strategy, overseeing program execution, and collaborating with key stakeholders to optimize the portfolio value and ensure effective communication and governance.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Serve as a thought partner for the NS & GTx unit head and leadership team on all topics related to strategy, portfolio strategy and program-level strategic considerations
Lead the strategic initiatives within NS GTx and contribute to development or enterprise-level initiatives
Co-lead the NS & GTx strategy review in collaboration with the NS & Gtx Head and other NS & GTx members; works in collaboration with NS & GTx leadership members and their respective organizations; prepares outputs for Novartis senior management, Board of Directors and external audiences (e.g., investors)
Proactively monitor external landscape (incl. industry, regulatory landscape etc.), assesses impact on portfolio and derives concrete actions / recommendations
Lead governance, effective discussion and quality decision making at NS & GTx Leadership team; Point person for portfolio & strategy related activities and requests
Lead effective internal and external communication to include IR and pipeline communications via generation or review of all NS & GTx level reports; lead development of strategic communication and associate engagement plan
Translate NS & GTx strategy into NS & GTx leadership team and development leadership team objectives jointly with GPTs and DU LFs; continuously tracks status
Optimize the portfolio value and update relevant NS & GTx strategy
Prepare (and support leadership team in preparation) for governance meetings, including in-writing memos and monthly updates. Liaising with governance boards to coordinate flow of review
May manage the NS & GTx Operational Manager(s) and have direct reports ranging from 1-5 associates
Accountable for external annual DU budget Planning and management of department headcount (10-20 FTEs) and oversight of the DU project development costs
Ensures resource optimization through influencing trial and program design by matching investment to portfolio prioritization and risk profile
Qualification
Required
Master's degree or equivalent education/degree in life sciences or healthcare and 10+ years of drug development experience, and knowledge of drug development strategy
5+ years people and matrix management experience
Excellent problem-solving, negotiation and conflict resolution skills
Considerable organizational awareness, including significant experience working cross-functionally and in global teams
Strong relationship builder and communicator with experience leading diverse work teams, driving program excellence, engaging functional partners, and partnering with disease unit Head and Business Franchise Head
Advanced planning and project management skills, with understanding of business processes
Preferred
MD, PhD or MBA highly desired
Global people management experience
Benefits
Health, life and disability benefits
A 401(k) with company contribution and match
A generous time off package including vacation, personal days, holidays and other leaves
Company
Novartis
Novartis is a pharmaceutical company that researches and develops medicines for serious diseases to improve and extend people's lives.
10001+ employees
H1B Sponsorship
Novartis has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (27)
2023 (23)
2022 (27)
2021 (31)
2020 (25)
Funding
Current Stage
Public CompanyTotal Funding
$2.49BKey Investors
Bill & Melinda Gates Foundation
2024-06-19Post Ipo Debt· $2.49B
2018-02-14Grant· $6.5M
2000-05-19IPO
Leadership Team
Daniel Grant
Vice President & Global Program Head
John von Brachel
VP, Head of Content Lab
Recent News
2026-01-23
2026-01-23
Company data provided by crunchbase